These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6519165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism.
    Lee MG, Chiou WL.
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):623-40. PubMed ID: 6678312
    [Abstract] [Full Text] [Related]

  • 5. Comparative bio-availability of four formulations of furosemide.
    Meyer BH, Müller FO, Swart KJ, Luus HG, Werkman IM.
    S Afr Med J; 1985 Oct 26; 68(9):645-7. PubMed ID: 3904040
    [Abstract] [Full Text] [Related]

  • 6. Variable furosemide absorption and poor predictability of response in elderly patients.
    Murray MD, Haag KM, Black PK, Hall SD, Brater DC.
    Pharmacotherapy; 1997 Oct 26; 17(1):98-106. PubMed ID: 9017769
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative bioavailability of two furosemide formulations in humans.
    Martin BK, Uihlein M, Ings RM, Stevens LA, McEwen J.
    J Pharm Sci; 1984 Apr 26; 73(4):437-41. PubMed ID: 6726624
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations.
    Meyer BH, Müller FO, Hundt HK, Grigoleit HG, Hajdu P, Heptner W.
    S Afr Med J; 1981 Jun 13; 59(25):891-3. PubMed ID: 7015536
    [Abstract] [Full Text] [Related]

  • 14. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
    Hatorp V, Oliver S, Su CA.
    Int J Clin Pharmacol Ther; 1998 Dec 13; 36(12):636-41. PubMed ID: 9877000
    [Abstract] [Full Text] [Related]

  • 15. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M.
    Clin Ther; 2009 Feb 13; 31(2):399-410. PubMed ID: 19302912
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of furosemide in patients with congestive heart failure.
    Greither A, Goldman S, Edelen JS, Benet LZ, Cohn K.
    Pharmacology; 1979 Feb 13; 19(3):121-31. PubMed ID: 523503
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bumetanide and furosemide.
    Brater DC, Chennavasin P, Day B, Burdette A, Anderson S.
    Clin Pharmacol Ther; 1983 Aug 13; 34(2):207-13. PubMed ID: 6872415
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.